Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
At the 2024 BioFuture conference held in October in New York City, GEN sat down with Xiaorong He, PhD, senior
Read MoreAt the 2024 BioFuture conference held in October in New York City, GEN sat down with Xiaorong He, PhD, senior
Read MoreHave you ever wondered why society is more focused on finding cures than on identifying causes? The answer is simple:
Read MoreSign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your
Read MoreIn pursuit of its strategy of vertical integration of its flagship healthcare and wellness business, MOHS Analytics has acquired majority
Read MoreVeeva’s VP of global medical, Christoph Bug, stated that Veeva has also invested in medical affairs. Image credit: Veeva. Pharmaceutical
Read MoreAlthough more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall
Read MoreThe medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare professionals (HCPs) and
Read MoreChina has approved 113 innovative drugs since its 14th five-year plan began in 2021, according to data shared at a
Read MoreMergers and acquisitions could make a comeback with Trump headed back to Washington. The 2024 presidential election and President-elect Donald
Read MoreThe rapid pace of technological advancement has outstripped the ability of traditional training programs to keep up, creating a significant
Read More